S. Jiménez de Ory

发表

A new tool for the paediatric HIV research: general data from the Cohort of the Spanish Paediatric HIV Network (CoRISpe)

P. Soler-Palacín, M. Muñoz-Fernandez, C. Fortuny, 2013, BMC Infectious Diseases.

Virological outcome among HIV infected patients transferred from pediatric care to adult units in Madrid, Spain (1997–2017)

P. Soler-Palacín, Á. Holguín, J. Losa, 2020, Scientific Reports.

Opportunistic infections and organ‐specific diseases in HIV‐1‐infected children: a cohort study (1990–2006)

M. Muñoz-Fernández, M. Muñoz-Fernandez, M. D. de José, 2010, HIV medicine.

Sociodemographic changes and trends in the rates of new perinatal HIV diagnoses and transmission in Spain from 1997 to 2015

M. Muñoz-Fernández, C. Fortuny, S. Jiménez de Ory, 2019, PloS one.

Innate and adaptive abnormalities in youth with vertically acquired HIV through a multicentre cohort in Spain

M. Muñoz-Fernández, L. Tarancón-Díez, S. Jiménez de Ory, 2021, Journal of the International AIDS Society.

Prognostic factors of a lower CD4/CD8 ratio in long term viral suppression HIV infected children

M. Muñoz-Fernández, P. Rojo, S. Jiménez de Ory, 2019, PloS one.

Impact of lopinavir-ritonavir exposure in HIV-1 infected children and adolescents in Madrid, Spain during 2000-2014

Á. Holguín, S. Jiménez de Ory, J. Ramos, 2017, PloS one.

Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain.

Á. Holguín, M. Muñoz-Fernández, M. de Mulder, 2011, The Journal of antimicrobial chemotherapy.

Causes of Death in Pediatric Patients Vertically Infected by the Human Immunodeficiency Virus Type 1 in Madrid, Spain, From 1982 to Mid-2009

M. Muñoz-Fernandez, S. Jiménez de Ory, J. Bellón, 2011, The Pediatric infectious disease journal.

Integrase inhibitors in children and adolescents: clinical use and resistance.

Á. Holguín, C. Fortuny, S. Jiménez de Ory, 2022, The Journal of antimicrobial chemotherapy.

Etravirine‐based highly active antiretroviral therapy in HIV‐1‐infected paediatric patients

M. Navarro, M. Muñoz-Fernandez, V. Briz, 2011, HIV Medicine.

Trends in Drug Resistance Prevalence, HIV-1 Variants and Clinical Status in HIV-1-infected Pediatric Population in Madrid: 1993 to 2015 Analysis

Á. Holguín, R. Delgado, P. Rojo, 2017, The Pediatric infectious disease journal.

Clinical, Immunological and Virological Outcomes among youths with perinatal HIV after Transition to Adult Units in Spain from 1997 to 2016.

M. Muñoz-Fernández, S. Jiménez de Ory, J. Bellón, 2020, Journal of acquired immune deficiency syndromes.

Clinical and virologic follow-up in perinatally HIV-1-infected children and adolescents in Madrid with triple-class antiretroviral drug-resistant viruses.

Á. Holguín, M. de Mulder, P. Rojo, 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

New diagnoses of human immunodeficiency virus infection in the Spanish pediatric HIV Cohort (CoRISpe) from 2004 to 2013

P. Soler-Palacín, M. Muñoz-Fernández, C. Fortuny, 2017, Medicine.

Mortality in Perinatally HIV-infected Adolescents After Transition to Adult Care in Spain.

S. Jiménez de Ory, J. T. Ramos Amador, C. Miralles, 2020, The Pediatric infectious disease journal.

Prevalence of M184V and K65R in proviral DNA from PBMCs in HIV-infected youths with lamivudine/emtricitabine exposure

P. Soler-Palacín, Á. Holguín, J. Losa, 2021, The Journal of antimicrobial chemotherapy.

Significant differences between verbal and non-verbal intellectual scales on a perinatally HIV-infected cohort: from pediatrics to young adults

R. Jurado-Barba, S. Jiménez de Ory, J. Ramos, 2020, Heliyon.

Sleep Profile and Self-Reported Neuropsychiatric Symptoms in Vertically HIV-Infected Adolescents on cART

M. Muñoz-Fernández, P. Rojo, S. Jiménez de Ory, 2018, Journal of Pediatric Infectious Diseases.

Long-term evolution in liver disease markers and immune and lipid profiles in vertically HIV/HCV-coinfected youths with sustained viral response after direct-acting antivirals therapy.

M. Laguno, L. Tarancón-Díez, S. Jiménez de Ory, 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Response to Direct Acting Antivirals for hepatitis C treatment in vertically HIV/HCV co-infected patients.

J. Burgos, C. Fortuny, S. Jiménez de Ory, 2020, Journal of Viral Hepatitis.